DEVLIN JODI (President, Therapeutics) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2025ACC: 0001415889-25-004680
Officer· President, Therapeutics
Since Aug 2023
+5.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.27K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.27K
Price / share
—
Trade value
—
% of position
18.7%
2/18/2025
28.13K→33.40K
Total
Net shares
+5.27K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2025 | A · Award | +5.27K | — | — | 18.7% | 28.13K | 33.40K |
| Total | +5.27K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported